GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Total Liabilities

Fabino Life Sciences (BOM:543444) Total Liabilities : ₹112.1 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Total Liabilities?

Fabino Life Sciences's Total Liabilities for the quarter that ended in Mar. 2024 was ₹112.1 Mil.

Fabino Life Sciences's quarterly Total Liabilities increased from Mar. 2023 (₹8.96 Mil) to Sep. 2023 (₹37.14 Mil) and increased from Sep. 2023 (₹37.14 Mil) to Mar. 2024 (₹112.13 Mil).

Fabino Life Sciences's annual Total Liabilities increased from Mar. 2022 (₹5.21 Mil) to Mar. 2023 (₹8.96 Mil) and increased from Mar. 2023 (₹8.96 Mil) to Mar. 2024 (₹112.13 Mil).


Fabino Life Sciences Total Liabilities Historical Data

The historical data trend for Fabino Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Total Liabilities Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Liabilities
Get a 7-Day Free Trial 29.16 9.49 5.21 8.96 112.13

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Liabilities Get a 7-Day Free Trial 5.21 1.49 8.96 37.14 112.13

Fabino Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Fabino Life Sciences's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=98.985+(12.691+0.45
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=112.1

Total Liabilities=Total Assets (A: Mar. 2024 )-Total Equity (A: Mar. 2024 )
=153.568-41.442
=112.1

Fabino Life Sciences's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=98.985+(12.691+0.45
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=112.1

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=153.568-41.442
=112.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Life Sciences (BOM:543444) Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines